Comparison of Different Doses of ACTH Used in ACTH Stimulation Test to Determine the Subtypes of Primary Aldosteronism

© 2024《四川大学学报(医学版)》编辑部 版权所有Copyright ©2024 Editorial Board of Journal of Sichuan University (Medical Sciences)..

Objective: To compare the diagnostic value of adrenocorticotropic hormone (ACTH) stimulation test (AST) with different doses of ACTH combined with midnight administration of 1 mg dexamethasone for the determination of the subtypes of primary hyperaldosteronism (PA).

Methods: This is a prospective observational study. Patients diagnosed with PA in the Department of Endocrinology, the First Medical Center of of Chinese PLA General Hospital from January 1, 2020 to September 30, 2022 underwent AST with different doses of ACTH. All patients received 1 mg dexamethasone at midnight for inhibition. Then, the patients were randomly assigned to 25-unit and 50-unit ACTH treatment groups by a ratio of 1:2. Subtype classification and diagnosis of aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism (IHA) was made on the basis of adrenal venous blood samples and/or postoperative pathology and clinical follow-up findings. Receiver operating characteristics (ROC) curves were plotted to examine the diagnostic efficacy and the difference of AST by varying doses of ACTH in distinguishing APA and IHA.

Results: A total of 82 patients, including 49 patients with APA (59.8%) and 33 patients with IHA (40.2%), were enrolled. There were 29 patients in the 25-unit ACTH group (35.4%) and 53 patients in the 50-unit ACTH group (64.6%). There were no significant differences in age, sex, blood pressure, minimum serum potassium, and biochemical parameters between the 25-unit and 50-unit groups. After ACTH stimulation, plasma aldosterone concentration (PAC), cortisol (F), and PAC/F at different points of time showed no statistical difference between the two groups (P>0.05). The area under the curve (AUC) of PAC in the 25-unit group was higher than that of PAC/F. The AUC of PAC reached the maximum at 90 minutes (0.948, 95% confidence interval [CI]: 0870-1.000) and the optimal cutoff was 38.0 ng/dL, which had a sensitivity of 92.9% and a specificity of 86.7% for differentiating APA and IHA. Similar to the 25-unit group, the maximum AUC of PAC in the 50-unit group was greater than that of PAC/F. The AUC of PAC reached the maximum 90 minutes (0.930, 95% CI: 0.840-0.994) and the optimal cutoff was 39.6 ng/dL, which had a sensitivity of 91.2% and a specificity of 83.3%. The AUC of PAC at different points of time in the 25-unit ACTH group (0.862-0.948) was greater than that of 50-unit ACTH group (0.823-0.930), but the difference was not statistical significance.

Conclusion: AST with 25-unit or 50-unit ACTH combined with small-dose dexamethasone can be used in PA subtype determination, ie, differentiation between APA and IHA. The optimal PAC cut-off values for 25-unit or 50-unit ACTH are similar, being 38.0 ng/dL and 39.6 ng/dL, respectively, and both cutoff values show higher sensitivity and specificity at 90 min. The AST with 25-unit ACTH has the smaller dose and the better safety. Therefore, it is recommended for the diagnosis of PA subtypes.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:55

Enthalten in:

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition - 55(2024), 1 vom: 20. Jan., Seite 210-216

Sprache:

Chinesisch

Weiterer Titel:

不同剂量促肾上腺皮质激素兴奋试验在原发性醛固酮增多症分型诊断中的比较

Beteiligte Personen:

Qiu, Ping [VerfasserIn]
Zang, Li [VerfasserIn]
Zhang, Li [VerfasserIn]
Lyu, Zhaohui [VerfasserIn]
Mu, Yiming [VerfasserIn]
Guo, Qinghua [VerfasserIn]

Links:

Volltext

Themen:

4964P6T9RB
7S5I7G3JQL
9002-60-2
ACTH stimulation test
Adrenocorticotropic Hormone
Aldosterone
Dexamethasone
English Abstract
Journal Article
Observational Study
Primary hyperaldosteronism
Prospective study
Subtype

Anmerkungen:

Date Completed 08.02.2024

Date Revised 12.03.2024

published: Print

Citation Status MEDLINE

doi:

10.12182/20240160105

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368117367